Astra Zeneca enters into cancer drug deal with potential value of $6 billion

Delaware Business Now

Jul 28, 2020

AstraZeneca entered into a new global development and commercialization agreement with Japan-based Daiichi Sankyo Company for a promising chemotherapy drug. The agreement has a pot…